Tubacex, S.A. (BME:TUB)

Spain · Delayed Price · Currency is EUR

2.900

-0.030 (-1.02%)

Apr 28, 2026, 5:35 PM CET

-22.36% (1Y)

Market Cap	355.85M
Revenue (ttm)	692.92M
Net Income (ttm)	-37.88M
Shares Out	122.71M
EPS (ttm)	-0.31
PE Ratio	n/a
Forward PE	15.87
Dividend	0.20 (6.95%)
Ex-Dividend Date	May 28, 2025

Volume	345,572
Average Volume	488,856
Open	2.960
Previous Close	2.930
Day's Range	2.885 - 2.960
52-Week Range	2.740 - 4.280
Beta	0.55
RSI	39.29
Earnings Date	Apr 24, 2026

About Tubacex

Tubacex, S.A., together with its subsidiaries, engages in the manufacturing and sale of stainless steel and nickel tubes in Spain and internationally. The company provides seamless stainless steel tubes, including CRA OCTG tubing and casing; aerospace, space exploration, and defense tubing; hydraulic and instrumentation tubing; heat exchanger tubing; subsea umbilicals; and medium and high pressure tubes, as well as machined components, including downhole mills, impellers, spiral mills, reamer, shoes, stabilizers, sensors, spools, bladed noses, ... [Read more]

Industry Steel

Sector Materials

Founded 1963

Employees 2,619

Stock Exchange Madrid Stock Exchange

Ticker Symbol TUB

Full Company Profile

Financial Performance

Financial Statements

News

Tubacex SA (STU:TCX) Q4 2025 Earnings Call Highlights: Navigating Market Challenges with ...

Tubacex SA (STU:TCX) Q4 2025 Earnings Call Highlights: Navigating Market Challenges with Strategic Growth

2 months ago - GuruFocus

Q4 2025 Tubacex SA Earnings Call Transcript

2 months ago - GuruFocus

Tubacex Earnings Call Transcript: Q4 2025

Sales declined 6.3% to EUR 719.3 million, but profitability remained stable with a 14.17% EBITDA margin. The Abu Dhabi plant ramped up, supporting a robust order book and strong premium product mix, while the outlook for 2026 remains cautious amid ongoing uncertainty.

2 months ago - Transcripts

Tubacex Earnings Call Transcript: Q2 2025

First half 2025 saw sales of EUR 361 million and EBITDA of EUR 61 million, with net profit up 140.9% year-over-year, driven by high-value contracts and the ADNOC license. Despite macroeconomic uncertainty and lower sales, margins and backlog remain strong, supporting a positive outlook.

9 months ago - Transcripts

Tubacex Earnings Call Transcript: Q4 2024

2024 saw major strategic advances, including a $200M Mubadala partnership, the launch of the Sentinel Prime connection, and strong multi-year contracts with ADNOC and Petrobras. EBITDA reached EUR 107M, with 2025 expected to be a record year as ADNOC billing begins.

1 year ago - Transcripts

Tubacex Earnings Call Transcript: Q2 2024

Sales reached EUR 398 million with a 12.6% EBITDA margin, impacted by the ADNOC project ramp-up and high working capital. The Mubadala partnership and Abu Dhabi plant are set to drive strong sales and margin growth in 2025, with financial ratios expected to normalize post-cash inflow.

1 year ago - Transcripts